Back to LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA

NVONVO

Showing 9 of 31 quarters

Position history for LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MALORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's holdings in Novo Nordisk A/S

Yes. Loring Wolcott & Coolidge Fiduciary Advisors holds 23,650 shares of NVO (Novo Nordisk), worth $896,573, as of its Q3 2026 13F filing. It reduced the position by 12,542 shares (-34.7%) from Q2 2026. Loring Wolcott & Coolidge Fiduciary Advisors has held NVO in every 13F on record since Q1 2019, 31 quarterly filings.

Current Value

$896,573

Current Shares

23,650

Total Value Change

-$2.8M

Total Shares Change

-8,481

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
23,650
-34.6%
$896,5730.0%$37.91
0
2026-Q2
Decreased
36,192
-65.7%
$1.7M0.0%$47.34
0
2026-Q1
Decreased
105,554
-1.7%
$4M0.0%$36.29
0
2025-Q4
Decreased
107,398
-4.1%
$6.8M0.1%$48.46
0
2025-Q3
Decreased
112,021
-5.3%
$6M0.1%$52.85
0
2025-Q2
Decreased
118,240
-2.3%
$8.2M0.1%$65.01
0
2025-Q1
Increased
121,030
+6.5%
$7.4M0.1%$65.40
29
2024-Q4
Increased
113,688
+253.8%
$9.9M0.1%$79.73
45
2024-Q3
Decreased
32,131
-2.0%
$3.7M0.0%$110.37
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used